Jeff Hsu Email

Executive Director: Translational & Clinical Pharmacology . Initial Therapeutics

Current Roles

Employees:
28
Revenue:
$2.2M
About
Initial Therapeutics is discovering and developing a new class of small-molecule medicines designed to halt pathogenic protein formation in the earliest stages.Initial’s approach is unique and starkly differentiated from protein degradation and other interventions that recognize and tackle proteins only after they have been fully formed.
Initial Therapeutics Address
285 east grand avenue
San Francisco, CA
United States
Initial Therapeutics Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.